Lv41
408 积分 2025-09-20 加入
Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis
53分钟前
已完结
MAIT Cell–Mediated Immune Mechanisms of Dialysis-Induced Peritoneal Fibrosis and Therapeutic Targeting
56分钟前
已完结
Efficacy and safety of anrikefon in patients with pruritus undergoing haemodialysis: multicentre, double blind, randomised placebo controlled phase 3 trial
1小时前
已关闭
Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes
1小时前
已完结
Single-cell analysis of proximal tubular cells with different DNA content reveals functional heterogeneity in the acute kidney injury to chronic kidney disease transition
1小时前
已完结
Predicting Remission in Anti-PLA2R Antibody-Associated Membranous Nephropathy: A Secondary Analysis of the GEMRITUX, MENTOR and STARMEN Trials
1小时前
已完结
Semaglutide in patients with overweight or obesity and chronic kidney disease without diabetes: a randomized double-blind placebo-controlled clinical trial
1小时前
已完结
ATGL regulates renal fibrosis by reprogramming lipid metabolism during the transition from AKI to CKD
1小时前
已完结
Comparative Effectiveness of Individual Sodium-Glucose Cotransporter 2 Inhibitors
1小时前
已完结
Advances and challenges in kidney fibrosis therapeutics
1小时前
已完结
皖公网安备34019202002308
